Skip to content

Clinical Evaluation of Two Toric Contact Lenses

Clinical Evaluation of Clariti Monthly Toric and Clariti 1 Day Toric

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05688657
Enrollment
42
Registered
2023-01-18
Start date
2022-10-22
Completion date
2022-12-05
Last updated
2023-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Brief summary

The study objective was to compare short-term clinical performance data of two toric contact lenses.

Detailed description

The aim of this non-dispensing fitting study was to evaluate the short-term clinical performance of a monthly toric contact lens when compared to a daily disposable toric contact lens after 15 minutes of daily wear each.

Interventions

DEVICELens A

Monthly Replacement Toric Silicone Hydrogel Contact Lens 15 minutes of daily wear

DEVICELens B

Daily Disposable Toric Silicone Hydrogel Contact Lens 15 minutes of daily wear

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

All participants received Lens A and then Lens B in fixed-sequence order.

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Is between 18 and 40 years of age (inclusive) * Has had a self-reported visual exam in the last two years * Is an adapted soft contact lens wearer * Is not a habitual wearer of either study lens * Has a contact lens spherical prescription between +4.00 to -9.00 (inclusive) best corrected visual acuity of 20/30 or better in either eye * Have contact lens prescription of no less than -0.75D of astigmatism and no more than -2.25 D in both eyes. * Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye. * Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses. * Has clear corneas and no active ocular disease * Has read, understood and signed the information consent letter. * Patient contact lens refraction should fit within the available parameters of the study lenses. * Is willing to comply with the wear schedule (at least 5 days per week, \> 8 hours/day assuming there are no contraindications for doing so). * Is willing to comply with the visit schedule

Exclusion criteria

* Has a CL prescription outside the range of the available parameters of the study lenses. * Has a spectacle cylinder less than -0.75D or more than -2.50 D of cylinder in either eye. * Has a history of not achieving comfortable CL wear (5 days per week; \> 8 hours/day) * Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye. * Presence of clinically significant (grade 2-4) anterior segment abnormalities * Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear. * Slit lamp findings that would contraindicate contact lens wear such as: * Pathological dry eye or associated findings * Pterygium, pinguecula, or corneal scars within the visual axis * Neovascularization \> 0.75 mm in from of the limbus * Giant papillary conjunctivitis (GCP) worse than grade 1 * Anterior uveitis or iritis (past or present) * Seborrheic eczema, Seborrheic conjunctivitis * History of corneal ulcers or fungal infections * Poor personal hygiene * Has a known history of corneal hypoesthesia (reduced corneal sensitivity) * Has aphakia, keratoconus or a highly irregular cornea. * Has Presbyopia or has dependence on spectacles for near work over the contact lenses. * Has undergone corneal refractive surgery. * Is participating in any other type of eye related clinical or research study.

Design outcomes

Primary

MeasureTime frameDescription
Subjective Handling Ratings on InsertionAt insertionSubjective handling ratings on insertion will be measured on a scale from 0-100, where (0= extremely uncomfortable) and 100 = better performance

Countries

Mexico

Participant flow

Pre-assignment details

Forty-two participants were screened. All participants wore Lens A for first 15 minutes and then wore Lens B for 15 minutes. All the participants who were in the study were included in the analysis. (n=42)

Participants by arm

ArmCount
All Study Participants
Includes all study participants.
42
Total42

Baseline characteristics

CharacteristicAll Study Participants
Age, Categorical
Lens A
<=18 years
0 Participants
Age, Categorical
Lens A
>=65 years
0 Participants
Age, Categorical
Lens A
Between 18 and 65 years
42 Participants
Age, Categorical
Lens B
<=18 years
0 Participants
Age, Categorical
Lens B
>=65 years
0 Participants
Age, Categorical
Lens B
Between 18 and 65 years
42 Participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
33 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 420 / 42
other
Total, other adverse events
0 / 420 / 42
serious
Total, serious adverse events
0 / 420 / 42

Outcome results

Primary

Subjective Handling Ratings on Insertion

Subjective handling ratings on insertion will be measured on a scale from 0-100, where (0= extremely uncomfortable) and 100 = better performance

Time frame: At insertion

Population: \[Not Specified\]

ArmMeasureValue (MEAN)Dispersion
Lens ASubjective Handling Ratings on Insertion92.0 units on a scaleStandard Deviation 13.1
Lens BSubjective Handling Ratings on Insertion93.7 units on a scaleStandard Deviation 9.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026